These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12557756)
1. Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities. Yazaki M; Connors LH; Eagle RC; Leff SR; Skinner M; Benson MD Amyloid; 2002 Dec; 9(4):263-7. PubMed ID: 12557756 [TBL] [Abstract][Full Text] [Related]
2. A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis. Yazaki M; Varga J; Dyck PJ; Benson MD Amyloid; 2002 Dec; 9(4):268-71. PubMed ID: 12557757 [TBL] [Abstract][Full Text] [Related]
3. [Transthyretin Arg-83 mutation in vitreous amyloidosis]. Chen L; Lü L; Zhang P; Li Y; Lin J Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962 [TBL] [Abstract][Full Text] [Related]
4. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid. Solano JM; Pulido JS; Salomao DR Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848 [TBL] [Abstract][Full Text] [Related]
5. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg. Long D; Zeng J; Wu LQ; Tang LS; Wang HL; Wang H Ophthalmic Genet; 2012 Mar; 33(1):28-33. PubMed ID: 21843040 [TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Liepnieks JJ; Wilson DL; Benson MD Amyloid; 2006 Sep; 13(3):170-7. PubMed ID: 17062384 [TBL] [Abstract][Full Text] [Related]
7. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738 [TBL] [Abstract][Full Text] [Related]
8. A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84. Skinner M; Harding J; Skare I; Jones LA; Cohen AS; Milunsky A; Skare J Ophthalmology; 1992 Apr; 99(4):503-8. PubMed ID: 1350083 [TBL] [Abstract][Full Text] [Related]
9. Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene. Sandgren O; Holmgren G; Lundgren E Arch Ophthalmol; 1990 Nov; 108(11):1584-6. PubMed ID: 1978774 [TBL] [Abstract][Full Text] [Related]
10. [Amyloidosis of the vitreous body. Possibilities of diagnosis]. Soltau JB; Seiberth V; Knorz MC; Liesenhoff H Fortschr Ophthalmol; 1991; 88(4):408-10. PubMed ID: 1786932 [TBL] [Abstract][Full Text] [Related]
11. A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome. Raivio VE; Jonasson J; Myllykangas L; Ala-Mello S; Kankuri-Tammilehto M; Kiuru-Enari S; Westermark P; Tanskanen M; Kivelä T Amyloid; 2016; 23(1):46-50. PubMed ID: 26828956 [TBL] [Abstract][Full Text] [Related]
12. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Munar-Qués M; Salva-Ladaria L; Mulet-Perera P; Solé M; López-Andreu FR; Saraiva MJ Amyloid; 2000 Dec; 7(4):266-9. PubMed ID: 11132095 [TBL] [Abstract][Full Text] [Related]
13. Immunostaining images of vitreous transthyretin amyloid. Latasiewicz M; Adan A; Solé M Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975 [TBL] [Abstract][Full Text] [Related]
14. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis. Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804 [TBL] [Abstract][Full Text] [Related]
15. Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis. Sandgren O; Holmgren G; Lundgren E; Steen L Arch Ophthalmol; 1988 Jun; 106(6):790-2. PubMed ID: 2897192 [TBL] [Abstract][Full Text] [Related]
16. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation. Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946 [TBL] [Abstract][Full Text] [Related]
17. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only. Ran LX; Zheng ZY; Xie B; Nie XM; Chen XW; Su G; Cai SJ Exp Eye Res; 2018 Apr; 169():13-19. PubMed ID: 29360446 [TBL] [Abstract][Full Text] [Related]
18. Transthyretin Ser-44 mutation in a case with vitreous amyloidosis. Murakami A; Fujiki K; Hasegawa S; Imamura S; Kawano H; Kanai A; Matsumoto T Am J Ophthalmol; 2002 Feb; 133(2):272-3. PubMed ID: 11812437 [TBL] [Abstract][Full Text] [Related]
19. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor. Zou X; Dong F; Zhang S; Tian R; Sui R Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977 [TBL] [Abstract][Full Text] [Related]
20. Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant. Treviño-Herrera AB; Bustamante-Vargas AP; Lisker-Cervantes A; Ríos Y Valles Valles D; Villanueva-Mendoza C; González-Duarte A; Concha-Del-Río LE Ophthalmic Genet; 2022 Jun; 43(3):413-419. PubMed ID: 35038954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]